SCPS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 11:06):

Stats
Today's Volume	189.00
Average Volume	1 879.00
Market Cap	88 377.00
EPS	$-0.0658 ( 2023-08-11 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0100
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-23	Greenspan Ira Scott	Sell	3 000 000	W Warrants
2021-11-23	Lamstein Joshua R	Sell	3 000 000	W Warrants
2021-06-01	Hopper Paul	Buy	6 333	Common Stock
2020-12-15	Hopper Paul	Buy	0	Common Stock
2020-12-15	Hopper Paul	Sell	0	Common Stock

INSIDER POWER
0.00
Last 55 transactions
Buy: 2 180 518 \| Sell: 6 965 870

Scopus Biopharma Inc. Correlation

10 Most Positive Correlations
UXIN	0.946
PLL	0.928
RNAZ	0.918
IRBT	0.914
OPI	0.912
AXDX	0.909
ALTM	0.902
VRM	0.902
PCSA	0.901
SNAX	0.9

10 Most Negative Correlations
FFNW	-0.941
FGFPP	-0.919
ISRG	-0.911
HQY	-0.904
SFBC	-0.891
SRPT	-0.883
ADTH	-0.88
AGNCO	-0.877
CLST	-0.876
PRAX	-0.872

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Scopus Biopharma Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.550

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.550

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.02

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.810

Financial Reports:

No articles found.

Scopus Biopharma Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Scopus Biopharma Inc.

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.